CLINICAL_TRIALS trial_result · 2020-03-31

Clinical Trial Update: Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

Phase 2 clinical trial of CK-2017357 in amyotrophic lateral sclerosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Cytokinetics | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2020-03-31